<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00213707</url>
  </required_header>
  <id_info>
    <org_study_id>2864</org_study_id>
    <nct_id>NCT00213707</nct_id>
  </id_info>
  <brief_title>Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.</brief_title>
  <official_title>Liver Transplanted Patients for HCV Related End Stage Liver Disease.Functional Role of Blood Circulating Dendritic Cells in the Pathogenesis of Hepatitis C Virus Infection During Liver Transplantation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Re-infection of the liver graft occurs universally following liver transplantation for
      HCV-induced end stage liver disease. Interestingly, the manifestation of HCV infection
      ranging from an asymptomatic carrier state to rapid progression to liver cirrhosis is
      extremely variable from one patient to another. The host and viral factors being responsible
      for the different course of HCV infection are poorly understood. Our study will focus on
      dendritic cells which are known to play a critical role in the control of viral infection.
      Viral factors (quasispecies evolution) will also be analysed and Th1 Th2 cytokines produced
      in the serum evaluated.Thirty liver transplanted patients will be included : 20 patients
      transplanted for HCV-related disease and 10 controls transplanted for non HCV-related
      disease. Blood samples will be taken just before transplantation and at different time
      -points up to 5 years after transplantation. Function of blood monocyte-derived DC will be
      evaluated. Circulating blood plasmacytoid (pDC) and myeloid DC (mDC) sub-populations will be
      enumerated. HCV quasispecies evolution will be analysed. This study may help to define
      prognostic markers on progression of hepatitis C in liver transplantation and allow the
      development of new immunotherapeutic drugs
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2003</start_date>
  <completion_date type="Anticipated">May 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Function of blood circulating DC at day 7 and 1, 3, 6, 9, 12 months, 2 and 5 years after liver transplantation depending on the clinical outcome (mild or severe hepatitis, cirrhosis).</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>HCV Infection</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum peripheral blood mononuclear cells
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients for liver transplantation indicated after chronic hepatitis C.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Liver transplanted HCV infected patients :

          -  Adults, HIV(-),HBV(-)

          -  liver transplanted for an end stage liver disease associated to HCV.

          -  Genotype determined

          -  written agreement to participate to the study

        Control patients :

          -  Adults, HIV(-), HBV(-), HCV(-)

          -  liver transplanted for a non HCV liver disease

          -  written agreement to participate to the study.

        Exclusion Criteria:

          -  HIV(+), HBV(+)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francoise Stoll-Keller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Francoise Stoll-Keller</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>February 24, 2009</last_update_submitted>
  <last_update_submitted_qc>February 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Christine GEILLER</name_title>
    <organization>Direction de la Recherche Clinique et de l'Innovation - HÃ´pitaux Universitaires de Strasbourg</organization>
  </responsible_party>
  <keyword>Dendritic cells</keyword>
  <keyword>liver transplantation</keyword>
  <keyword>hepatitis C virus</keyword>
  <keyword>quasispecies</keyword>
  <keyword>virological markers</keyword>
  <keyword>biochemical markers</keyword>
  <keyword>immunological markers</keyword>
  <keyword>clinical markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

